SGLT2: new approaches to combination therapy of type 2 diabetes mellitus

SGLT2: new approaches to combination therapy of type 2 diabetes mellitus

Despite the emergence of new antidiabetic drugs, diabetes type 2 treatment remains a relevant issue. In order to standardize and optimize medical care to patients with diabetes, global and national algorithms for type 2 diabetes treatment were developed. [1, 2] The current algorithms focus on an ind...

Full description

Bibliographic Details
Main Authors:	I. V. Kononenko, O. M. Smirnova
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2016-12-01
Series:	Медицинский совет
Subjects:	сахарный диабет 2-го типа комбинированная терапия инсулинорезистентность дисфункция бета-клеток метформин ингибитор sglt2 дапаглифлозин type 2 diabetes combination therapy insulin resistance beta cell dysfunction metformin sglt2 inhibitor dap
Online Access:	https://www.med-sovet.pro/jour/article/view/53

Similar Items

Peculiarities of hypoglycaemic therapy in acute coronary syndrome in patients with type 2 diabetes mellitus
by: K. Yu. Nikolaev, et al.
Published: (2021-06-01)

Ketoacidosis as unexpected adverse reaction SGLT<sub>2</sub> inhibitor
by: T. M. Bukatina, et al.
Published: (2018-02-01)

Novye vozmozhnosti korrektsii disfunktsiiendoteliya u bol'nykh insulinrezistentnymsakharnym diabetom 2 tipa
by: T Yu Demidova, et al.
Published: (2006-09-01)

Dinamika klyuchevykh mediatorov insulinorezistentnosti u bol'nykh sakharnym diabetom 2 tipa pri primenenii metformina (Formin Pliva?)
by: Mikhail Ivanovich Balabolkin, et al.
Published: (2004-12-01)

Алоглиптин – высокоселективный ингибитор ДПП-4 с фокусом на кардиоваскулярную безопасность
Published: (2016-12-01)

The efficacy of metformin in the treatment of type 2 diabetes
by: А. S. Ametov, et al.
Published: (2016-12-01)

Relationship between metformin and frailty syndrome in elderly people with type 2 diabetes
by: Svetlana Igorevna Andreeva
Published: (2015-03-01)

CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE
by: I. E. Sapozhnikova, et al.
Published: (2016-01-01)

Insulinorezistentnost' pri sakharnom diabete tipa 1 u podrostkov: lechenie Sioforom? (metforminom)
by: Tamara Leonidovna Kuraeva
Published: (2003-03-01)

A clinical case of acute coronary syndrome in patients with type 2 diabetes
by: S. V. Kakorin, et al.
Published: (2015-12-01)

Avandiya ostaetsya odnim iz preparatov vybora v lechenii sakharnogo diabeta 2 tipa
by: Mikhail Ivanovich Balabolkin, et al.
Published: (2008-03-01)

METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES
by: M. E. Statsenko, et al.
Published: (2015-09-01)

Effektivnost' i mesto siofora (metformina) v terapii sakharnogo diabeta 2 tipa
by: Mikhail Ivanovich Balabolkin, et al.
Published: (2001-03-01)

Canagliflozin and risk of amputation in patients with type 2 diabetes
by: T. M. Bukatina, et al.
Published: (2018-02-01)

Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis
by: T. M. Bukatina, et al.
Published: (2018-02-01)

Dvukhfaznyy insulin aspart 30 plyusmetformin: effektivnaya kombinatsiyadlya lecheniya sakharnogo diabeta 2 tipa
by: M Kvapil, et al.
Published: (2006-06-01)

SGLT2 inhibitors: control of glycemia and nephroprotection properties
by: A. A. Volodin, et al.
Published: (2018-02-01)

Adipokines and metabolic parameters in patients with type 2 diabetes mellitus in combination with gout
by: Andrey F. Verbovoy, et al.
Published: (2015-09-01)

ADIPONECTIN, RESISTIN AND HORMONE-METABOLIC PARAMETERS IN MEN WITH HYPOTHYROIDISM AND TYPE 2 DIABETES MELLITUS
by: Андрей Феликсович Вербовой, et al.
Published: (2018-12-01)

Vzaimosvyaz' adiponektina, endotelinai insulinorezistentnosti u bol'nykh ozhireniemi sakharnym diabetom 2 tipa
Published: (2010-06-01)

Непрерывное мониторирование гликемии при сахарном диабете 2-го типа
Published: (2013-12-01)

Kombinirovannaya terapiya preparatom Glibomet bol'nykh sakharnym diabetom tipa 2
by: O E Solov'eva, et al.
Published: (2003-03-01)

Kliniko-farmakologicheskie aspekty titirovaniya dozirovki metformina
by: O I Karpov
Published: (2007-09-01)

Opyt primeneniya Dibikora pri sakharnom diabete 2 tipa
by: Marina Vladimirovna Shestakova, et al.
Published: (2007-03-01)

ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2015-09-01)

Diastolicheskaya disfunktsiya levogo zheludochka u bol'nykh sakharnym diabetom 2 tipa
by: Alexander Sergeevich Ametov, et al.
Published: (2008-03-01)

Nonalcoholic fatty liver disease in patients with type 2 diabetes
by: N. A. Petunina, et al.
Published: (2016-12-01)

Erektil'naya disfunktsiya u bol'nykh s maloy dlitel'nost'yu sakharnogo diabeta 2 tipa
by: Roman Viktorovich Rozhivanov, et al.
Published: (2004-09-01)

ВИЧ шагает по стране
by: Editorial Article
Published: (2014-12-01)

EFFECTIVENESS OF REAMBERIN IN CORRECTION OF OXIDATIVE STRESS SYNDROME IN PATIENTS WITH PHLEGMONOUS AND GANGRENOUS ERYSIPELAS AGAINST THE BACKGROUND OF THE 2 TYPE DIABETES MELLITUS
by: I. I. Zeleny, et al.
Published: (2018-01-01)

Interrelation of antropometric, labolatories parametres of metabolic syndrom and dermatoglyphic features unde type 2 diabetes
by: M Y Yakusheva, et al.
Published: (2009-12-01)

Effect of metformin on the bioavailability of nitric oxide in patients with type 2 diabetes
Published: (2012-03-01)

Farmakoekonomicheskiy analiz ispol'zovaniya intensivnoy taktiki lecheniya bol'nykh sakharnym diabetom 2 tipa
by: Olga Mikhailovna Smirnova
Published: (2004-12-01)

Liraglyutid - novaya stupen' v terapii SD 2 tipa
by: Marina Vladimirovna Shestakova
Published: (2008-09-01)

IDENTIFICATION OF RISK GROUPS FOR TYPE 2 DIABETES MELLITUS BASED ON FINDRISС QUESTIONNAIRE
by: I. V. Misnikova, et al.
Published: (2016-02-01)

Clinical efficacy and safety of linagliptin in patients with diabetes type 2
by: E. V. Biryukova, et al.
Published: (2016-12-01)

Seborrheic keratosis and insulin resistans
by: A. K. Aleksandrova, et al.
Published: (2017-08-01)

The role of the sympathoadrenal system and adipokines in the development of arterial hypertension in type 2 diabetes mellitus and obesity
Published: (2012-03-01)

Sravnenie kombinatsiy insulina lizpromiks 25 s metforminom i insulina glarginas metforminom pri lechenii patsientovs sakharnym diabetom 2 tipa,ranee ne poluchavshikh insulinoterapii(16-nedel'noe randomizirovannoe otkrytoeperekrestnoe issledovanie)
by: J K Malone, et al.
Published: (2006-06-01)

ЭФФЕКТИВНОСТЬ ЛЕЧЕНИЯ ДИАБЕТИЧЕСКОЙ ДИСЛИПИДЕМИИ РОЗУВАСТАТИНОМ И ЭЗЕТИМИБОМ У БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ ТИПА 2
by: Д.А. Урунбаева, et al.
Published: (2020-11-01)